亲爱的研友该休息了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!身体可是革命的本钱,早点休息,好梦!

The efficacy and safety of remimazolam besylate, ciprofol, and propofol during hysteroscopy

异丙酚 医学 宫腔镜检查 麻醉 外科
作者
Weifeng Shan,Shuying Gao,Mengting Ai,Haiyan Lan,Gongchen Duan,Xiaoli Dong,Qiaomin Xu,Yini Wu,Jimin Wu
出处
期刊:Frontiers in Pharmacology [Frontiers Media]
卷期号:15: 1427755-1427755 被引量:1
标识
DOI:10.3389/fphar.2024.1427755
摘要

Objective Remimazolam besylate and Ciprofol are newer sedatives used in minor surgeries. Propofol is a classic drug mainly used for short surgeries. This trial was conducted to compare the efficacy and safety of remimazolam besylate, ciprofol, and propofol during hysteroscopic surgeries. Methods Patients undergoing hysteroscopy were randomly assigned to receive remimazolam besylate (Group R), ciprofol (Group C), or propofol (Group P). A total of 194 patients were assessed for eligibility. One patient in Group P was excluded because the operation had timed out of 60 min. Patients all in Group R、Group C and Group P received an induction dose of 0.2 mg/kg remimazolam besylate、0.4 mg/kg ciprofol、2.0 mg/kg propofol seperately over 30 s. A corresponding dosage of 1 mg/kg/h、0.6–1.2 mg/kg/h and 3.0–6.0 mg/kg/h was given by continuous intravenous infusion to maintain a BIS of 40–60 till the end of the surgery. The incidence rates of body movement, respiratory depression, and adverse effects were compared among the groups. Results The incidence of injection pain was much higher in Group P (64.1%) than that in Group R (3.4%) and Group C (3.2%, both P < 0.001). The onset time was significantly shorter in Group P than that in Group R and Group C (both P < 0.01). The awakening time (MOAA/S score = 3) was longest in Group R, followed by Groups C and Group P ( P < 0.01). The time to complete recovery (MOAA/S score = 5) has no significantly difference between Group C and Group P, whereas the onset time was significantly shorter in Group R ( P < 0.01). The number of body movements was significantly higher in Group R than that in Group C and Group P ( P < 0.01). The incidence of hypotension was significantly lower in Group R than that in Group C and Group P (both P < 0.01). The rate of respiratory inhibition was significantly lower in Group R and Group C than that in Group P (both P < 0.05). Conclusion Considering jointly the safety and efficacy, ciprofol seems to be the best choice for sedation.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
一彤完成签到,获得积分10
23秒前
一种信仰完成签到 ,获得积分10
1分钟前
英俊的铭应助科研通管家采纳,获得10
1分钟前
minnie完成签到 ,获得积分10
1分钟前
可爱的函函应助hhkkk采纳,获得10
2分钟前
AllRightReserved完成签到 ,获得积分10
2分钟前
2分钟前
大模型应助冬天该很好采纳,获得10
3分钟前
小白完成签到,获得积分10
3分钟前
草木完成签到 ,获得积分10
3分钟前
慕青应助科研通管家采纳,获得10
3分钟前
科研通AI2S应助科研通管家采纳,获得10
3分钟前
John完成签到 ,获得积分10
3分钟前
4分钟前
4分钟前
量子星尘发布了新的文献求助10
6分钟前
6分钟前
斯文败类应助自由抽屉采纳,获得10
6分钟前
hhkkk发布了新的文献求助10
6分钟前
merilynht完成签到,获得积分10
6分钟前
6分钟前
自由抽屉发布了新的文献求助10
6分钟前
hhkkk完成签到,获得积分10
7分钟前
科研通AI2S应助科研通管家采纳,获得10
7分钟前
大模型应助科研通管家采纳,获得10
7分钟前
8分钟前
nk完成签到 ,获得积分10
8分钟前
9分钟前
彭于晏应助科研通管家采纳,获得10
9分钟前
AprilLeung完成签到 ,获得积分10
10分钟前
trophozoite完成签到 ,获得积分10
10分钟前
青柠发布了新的文献求助10
11分钟前
So完成签到 ,获得积分10
11分钟前
凸迩丝儿完成签到 ,获得积分10
11分钟前
11分钟前
矮小的向雪完成签到 ,获得积分10
11分钟前
11分钟前
zhaohl发布了新的文献求助10
11分钟前
11分钟前
尔作发布了新的文献求助10
11分钟前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Kinesiophobia : a new view of chronic pain behavior 2000
Burger's Medicinal Chemistry, Drug Discovery and Development, Volumes 1 - 8, 8 Volume Set, 8th Edition 1800
Cronologia da história de Macau 1600
文献PREDICTION EQUATIONS FOR SHIPS' TURNING CIRCLES或期刊Transactions of the North East Coast Institution of Engineers and Shipbuilders第95卷 1000
BRITTLE FRACTURE IN WELDED SHIPS 1000
Lloyd's Register of Shipping's Approach to the Control of Incidents of Brittle Fracture in Ship Structures 1000
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 纳米技术 计算机科学 化学工程 生物化学 物理 复合材料 内科学 催化作用 物理化学 光电子学 细胞生物学 基因 电极 遗传学
热门帖子
关注 科研通微信公众号,转发送积分 6151067
求助须知:如何正确求助?哪些是违规求助? 7979692
关于积分的说明 16575375
捐赠科研通 5262704
什么是DOI,文献DOI怎么找? 2808653
邀请新用户注册赠送积分活动 1788907
关于科研通互助平台的介绍 1656950